Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kruppel-like factor 5 (KLF5) is a transcription factor that plays a role in cell proliferation and differentiation by regulating the expression of genes involved in these processes. It is known to interact with co-activators like CBP to enhance its transactivation function, and its activity can be modulated by phosphorylation. KLF5 is involved in tumorigenesis and has been implicated in the regulation of genes such as cyclin D1 and cyclin B1, which are crucial for cell cycle progression. Its expression is often increased in transformed cells and can be influenced by various signaling pathways, including oncogenic H-Ras signaling.
Regulation of target gene expression through binding to GC-rich DNA sequences; interaction with co-activators like CBP enhances its transactivation function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kruppel-like factor 5 (KLF5).